TY - JOUR AU - van Leenders, Geert J. L. H. PY - 2019 TI - PD-L1 testing in urothelial carcinoma: are we there yet? JF - Translational Andrology and Urology; Vol 8, Supplement 5 (December 31, 2019): Translational Andrology and Urology Y2 - 2019 KW - N2 - Cisplatinum-based chemotherapy is the standard treatment modality of patients with locally advanced or metastatic urothelial cell carcinoma. Due to its toxicity, however, a significant number of patients is ineligible for this treatment. UR - https://tau.amegroups.org/article/view/30381